silicon phthalocyanine pc4 has been researched along with 1,2-dipalmitoylphosphatidylcholine in 1 studies
| Studies (silicon phthalocyanine pc4) | Trials (silicon phthalocyanine pc4) | Recent Studies (post-2010) (silicon phthalocyanine pc4) | Studies (1,2-dipalmitoylphosphatidylcholine) | Trials (1,2-dipalmitoylphosphatidylcholine) | Recent Studies (post-2010) (1,2-dipalmitoylphosphatidylcholine) |
|---|---|---|---|---|---|
| 113 | 1 | 63 | 4,158 | 20 | 1,262 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antunez, AR; Jafri, A; Megerian, CA; Stepnick, DW; Werning, JW; Zaidi, SI | 1 |
1 other study(ies) available for silicon phthalocyanine pc4 and 1,2-dipalmitoylphosphatidylcholine
| Article | Year |
|---|---|
Metoclopramide enhances the effect of photodynamic therapy on xenografted human squamous cell carcinoma of the head and neck.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Carriers; Head and Neck Neoplasms; Humans; Indoles; Liposomes; Metoclopramide; Mice; Mice, Nude; Neoplasm Transplantation; Organosilicon Compounds; Photochemotherapy; Photosensitizing Agents; Remission Induction; Silanes; Transplantation, Heterologous; Tumor Cells, Cultured | 1995 |